US2014363809A1PendingUtilityA1

Compositions and methods for detecting certain flaviviruses including members of the japanese encephalitis virus serogroup

Assignee: ROCHE MOLECULAR SYSTEMS INCPriority: Mar 31, 2003Filed: Aug 22, 2014Published: Dec 11, 2014
Est. expiryMar 31, 2023(expired)· nominal 20-yr term from priority
C12Q 2600/158C12Q 1/701C12Q 1/6888Y02A50/30
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides rapid and accurate methods, primers, probes and kits for identifying the presence of a certain flaviviruses in a sample. Flaviviruses that can be detected include members of the Japanese encephalitis virus serogroup, Dengue virus, St. Louis encephalitis virus, Montana myotis leukoencephalitis virus, Modoc virus, and Yellow Fever virus. The primers and probes of the invention can hybridize to regions in the 3′ untranslated region of the viral genomes to be detected.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for detecting the presence or absence of a St. Louis encephalitis virus (SLEV) nucleic acid in a sample, the method comprising:
 contacting the sample with a nucleic acid polymerase and a plurality of primers and a probe;   amplifying at least a portion of an SLEV 3′ untranslated region (UTR), the SLEV 3′ UR region selected from SEQ ID NO: 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, and 40, thereby generating an amplicon if the SLEV 3′ UTR is present in the sample; and   detecting the presence or absence of specific binding of the probe to the portion, thereby detecting the presence or absence of a St. Louis encephalitis virus (SLEV) nucleic acid in the sample.   
     
     
         2 . The method of  claim 1 , wherein the plurality of primers comprises one or more primer comprising a sequence selected from SEQ ID NO: 64, 66, 68, or 69. 
     
     
         3 . The method of  claim 1 , wherein the plurality of primers comprises a primer comprising SEQ ID NO:4. 
     
     
         4 . The method of  claim 1 , wherein the probe is detectably-labeled. 
     
     
         5 . The method of  claim 1 , wherein at least one of the plurality of primers is at least 30 nucleotides long.

Join the waitlist — get patent alerts

Track US2014363809A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.